Products /
Rimidi Cardiometabolic Management Platform
Contents
HELPFUL TOOLS
Rimidi Cardiometabolic Management Platform Comparisons
COVID-19
Pediatric
Integrations: | Ambulatory EMR, Credentialing, Other |
EMR Integration & Relevant Hardware: | Recommended, but not required |
EMRs Supported: | Epic, Cerner, NextGen, Athenahealth, athena |
Hardware Compatibility: | Desktop, Mobile / Tablet (web optimized) |
In Cerner App Gallery: | |
In Epic App Orchard: |
Rimidi’s cardiometabolic platform supports disease management of some of the most prevalent and costly chronic conditions. The platform provides access to the tools required to manage multiple disease states – Diabetes, Cardiovascular Disease/Hypertension, Heart Failure, Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH), and Obesity. The platform consolidates relevant clinical data from the EMR for each disease state with patient-generated health data from connected devices or surveys, and layers clinical decision support that can be mapped against national or practice guidelines. Our cardiometabolic snapshot allows clinicians to quickly assess patient status for each comorbid disease state -- are screenings up to date? Are key metrics well-controlled?
Data has so far shown that people with pre-existing conditions like diabetes and hypertension are more likely to have worse COVID-19 outcomes. While the need to provide continual, virtual models of care to better manage chronic conditions has always been important, it's especially important during COVID-19 to reduce risk of COVID-19 exposure in healthcare settings, and to ensure that the highest risk populations are still getting the care they need.
Rimidi has developed a view specifically for tracking gaps in care in Pediatric Obesity, a major risk factor for future development of cardiometabolic conditions.
Clinicians, care teams
In the sales process, we often hear “Doesn’t Epic (or other EHR) do that?” Rimidi is not built to replace the EHR, but to enhance it by bringing in additional data sets, providing more efficient workflows, and improving the user experience. Rimidi can install and configure its platform within 3-6 weeks which is significantly faster and more cost effective than onsite EHR teams can build and support enhancements to meet clinical needs. Rimidi’s modern technology stack enables rapid cycle innovation and iteration post-go live.
Rimidi’s cardiometabolic platform is most often compared to other Remote Patient Monitoring solutions, but the platform-approach to RPM allows Rimidi to do so much more. Some key differentiators of the Rimidi platform are: (1) tight integration with leading EHRs via SMART on FHIR, (2) the breadth of the comorbid disease states we cover, (3) our incorporations of patient-reported outcomes and social determinants of health measures and (4) our Clinical Decision Support engine. Rimidi’s CDS cards support almost any insight or intervention a client wants: RPM data alerting and interventions, referral management, lab or medication recommendations, clinical trial identification, and more.
Rimidi Cardiometabolic Management Platform Comparisons